Signaling by a Conserved Quorum Sensing Pathway Contributes to Growth Ex Vivo and Oropharyngeal Colonization of Human Pathogen Group A Streptococcus

ABSTRACT Bacterial virulence factor production is a highly coordinated process. The temporal pattern of bacterial gene expression varies in different host anatomic sites to overcome niche-specific challenges. The human pathogen group A streptococcus (GAS) produces a potent secreted protease, SpeB, that is crucial for pathogenesis. Recently, we discovered that a quorum sensing pathway comprised of a leaderless short peptide, SpeB-inducing peptide (SIP), and a cytosolic global regulator, RopB, controls speB expression in concert with bacterial population density. The SIP signaling pathway is active in vivo and contributes significantly to GAS invasive infections. In the current study, we investigated the role of the SIP signaling pathway in GAS-host interactions during oropharyngeal colonization. The SIP signaling pathway is functional during growth ex vivo in human saliva. SIP-mediated speB expression plays a crucial role in GAS colonization of the mouse oropharynx. GAS employs a distinct pattern of SpeB production during growth ex vivo in saliva that includes a transient burst of speB expression during early stages of growth coupled with sustained levels of secreted SpeB protein. SpeB production aids GAS survival by degrading LL37, an abundant human antimicrobial peptide. We found that SIP signaling occurs during growth in human blood ex vivo. Moreover, the SIP signaling pathway is critical for GAS survival in blood. SIP-dependent speB regulation is functional in strains of diverse emm types, indicating that SIP signaling is a conserved virulence regulatory mechanism. Our discoveries have implications for future translational studies.

[1]  M. Savitski,et al.  Leaderless secreted peptide signaling molecule alters global gene expression and increases virulence of a human bacterial pathogen , 2017, Proceedings of the National Academy of Sciences.

[2]  Michael Otto,et al.  Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance , 2017, Nature Reviews Drug Discovery.

[3]  M. Kumaraswami,et al.  Structural Mechanisms of Peptide Recognition and Allosteric Modulation of Gene Regulation by the RRNPP Family of Quorum-Sensing Regulators. , 2016, Journal of molecular biology.

[4]  J. Carapetis,et al.  Status of research and development of vaccines for Streptococcus pyogenes. , 2016, Vaccine.

[5]  Michael E. Watson,et al.  Animal Models of Streptococcus pyogenes Infection , 2016 .

[6]  J. Carapetis,et al.  Global Disease Burden of Group A Streptococcus , 2016 .

[7]  Manisha Pandey,et al.  Streptococcus pyogenes: Basic Biology to Clinical Manifestations: Current Approaches to Group A Streptococcal Vaccine Development. , 2016 .

[8]  G. Karthikeyan,et al.  Acute rheumatic fever and rheumatic heart disease , 2015, Nature Reviews Disease Primers.

[9]  D. Stevens,et al.  Current Approaches to Group A Streptococcal Vaccine Development -- Streptococcus pyogenes: Basic Biology to Clinical Manifestations , 2016 .

[10]  Stevens Dl,et al.  Global Disease Burden of Group A Streptococcus -- Streptococcus pyogenes: Basic Biology to Clinical Manifestations , 2016 .

[11]  S. W. Long,et al.  The Majority of 9,729 Group A Streptococcus Strains Causing Disease Secrete SpeB Cysteine Protease: Pathogenesis Implications , 2015, Infection and Immunity.

[12]  R. Olsen,et al.  A molecular trigger for intercontinental epidemics of group A Streptococcus. , 2015, The Journal of clinical investigation.

[13]  Jennifer L. Martin,et al.  Targeting virulence not viability in the search for future antibacterials. , 2015, British journal of clinical pharmacology.

[14]  R. Olsen,et al.  Adhesin competence repressor (AdcR) from Streptococcus pyogenes controls adaptive responses to zinc limitation and contributes to virulence , 2014, Nucleic acids research.

[15]  D. Conway,et al.  Salivary antimicrobial proteins associate with age-related changes in streptococcal composition in dental plaque. , 2014, Molecular oral microbiology.

[16]  M. Federle,et al.  Quorum sensing in group A Streptococcus , 2014, Front. Cell. Infect. Microbiol..

[17]  S. W. Long,et al.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences , 2014, Proceedings of the National Academy of Sciences.

[18]  Ken Smith,et al.  Inactivation of the CovR/S Virulence Regulator Impairs Infection in an Improved Murine Model of Streptococcus pyogenes Naso-Pharyngeal Infection , 2013, PloS one.

[19]  A. Ralph,et al.  Group a streptococcal diseases and their global burden. , 2013, Current topics in microbiology and immunology.

[20]  G. Menexes,et al.  Salivary concentration of the antimicrobial peptide LL-37 in children. , 2012, Archives of oral biology.

[21]  M. Federle,et al.  The Cryptic Competence Pathway in Streptococcus pyogenes Is Controlled by a Peptide Pheromone , 2012, Journal of bacteriology.

[22]  R. Olsen,et al.  Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. , 2012, The American journal of pathology.

[23]  R. Olsen,et al.  An amino‐terminal signal peptide of Vfr protein negatively influences RopB‐dependent SpeB expression and attenuates virulence in Streptococcus pyogenes , 2011, Molecular microbiology.

[24]  M. Aumont-Nicaise,et al.  A cell–cell communication system regulates protease production during sporulation in bacteria of the Bacillus cereus group , 2011, Molecular microbiology.

[25]  J. Musser,et al.  From transcription to activation: how group A streptococcus, the flesh‐eating pathogen, regulates SpeB cysteine protease production , 2011, Molecular microbiology.

[26]  M. Federle,et al.  Two Group A Streptococcal Peptide Pheromones Act through Opposing Rgg Regulators to Control Biofilm Development , 2011, PLoS pathogens.

[27]  R. Olsen,et al.  Niche‐specific contribution to streptococcal virulence of a MalR‐regulated carbohydrate binding protein , 2011, Molecular microbiology.

[28]  R. Olsen,et al.  Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice. , 2011, The Journal of clinical investigation.

[29]  A. Horswill,et al.  Peptide signaling in the staphylococci. , 2011, Chemical reviews.

[30]  M. Federle,et al.  A novel double‐tryptophan peptide pheromone controls competence in Streptococcus spp. via an Rgg regulator , 2010, Molecular microbiology.

[31]  A. Horswill,et al.  agr-Dependent Interactions of Staphylococcus aureus USA300 with Human Polymorphonuclear Neutrophils , 2010, Journal of Innate Immunity.

[32]  Yuriy Fofanov,et al.  Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics , 2010, Proceedings of the National Academy of Sciences.

[33]  V. Sperandio,et al.  Anti-virulence strategies to combat bacteria-mediated disease , 2010, Nature Reviews Drug Discovery.

[34]  Adeline R. Whitney,et al.  Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis , 2010, Proceedings of the National Academy of Sciences.

[35]  C Jeffrey Brinker,et al.  Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria. , 2010, Nature chemical biology.

[36]  E. Hanski,et al.  Functional Analysis of the Quorum-Sensing Streptococcal Invasion Locus (sil) , 2009, PLoS pathogens.

[37]  R. Olsen,et al.  Molecular mechanisms underlying group A streptococcal pathogenesis , 2009, Cellular microbiology.

[38]  A. Norrby-Teglund,et al.  Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans , 2008, Infection and Immunity.

[39]  J. Musser,et al.  A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus , 2008, Proceedings of the National Academy of Sciences.

[40]  M. Whiteley,et al.  Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum , 2007, Journal of bacteriology.

[41]  James M. Musser,et al.  Contribution of Exogenous Genetic Elements to the Group A Streptococcus Metagenome , 2007, PloS one.

[42]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[43]  J. Musser,et al.  Growth Characteristics of and Virulence Factor Production by Group A Streptococcus during Cultivation in Human Saliva , 2005, Infection and Immunity.

[44]  M. Zanetti.  Cathelicidins, multifunctional peptides of the innate immunity , 2004, Journal of leukocyte biology.

[45]  M. Neely,et al.  Role of RopB in Growth Phase Expression of the SpeB Cysteine Protease of Streptococcus pyogenes , 2003, Journal of bacteriology.

[46]  A. Schmidtchen,et al.  Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.

[47]  D. Lereclus,et al.  A cell–cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group , 2002, The EMBO journal.

[48]  A V Nieuw Amerongen,et al.  Saliva--the defender of the oral cavity. , 2002, Oral diseases.

[49]  D. Bessen,et al.  Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci , 2000, Molecular microbiology.

[50]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[51]  J. Musser,et al.  Extracellular Cysteine Protease Produced by Streptococcus pyogenes Participates in the Pathogenesis of Invasive Skin Infection and Dissemination in Mice , 1999, Infection and Immunity.

[52]  J. Musser,et al.  Genetic Inactivation of an Extracellular Cysteine Protease (SpeB) Expressed by Streptococcus pyogenes Decreases Resistance to Phagocytosis and Dissemination to Organs , 1998, Infection and Immunity.

[53]  J. Musser,et al.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.

[54]  P. Cleary,et al.  Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus , 1997, Infection and immunity.

[55]  G. Dunny,et al.  Cell-cell communication in gram-positive bacteria. , 1997, Annual review of microbiology.

[56]  J. Hoch,et al.  Cell-cell communication regulates the effects of protein aspartate phosphatases on the phosphorelay controlling development in Bacillus subtilis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Eisenberg.  Rheumatic heart disease in the developing world: prevalence, prevention, and control. , 1993, European heart journal.

[58]  V. Chaudhary,et al.  Rheumatic heart disease: a school survey in a rural area of Rajasthan. , 1992, Indian heart journal.

[59]  H. Courtney,et al.  Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells , 1991, Infection and immunity.

[60]  L. Wannamaker,et al.  The Chain that Links the Heart to the Throat , 1973, Circulation.

[61]  P. Ross.  Beta-haemolytic streptococci in saliva , 1971, Journal of Hygiene.

[62]  R. Lancefield.  PERSISTENCE OF TYPE-SPECIFIC ANTIBODIES IN MAN FOLLOWING INFECTION WITH GROUP A STREPTOCOCCI , 1959, The Journal of experimental medicine.

[63]  O. H. Robertson,et al.  Expulsion of group A hemolytic streptococci in droplets and droplet nuclei by sneezing, coughing and talking. , 1948, The American journal of medicine.

[64]  M. Hamburger.  Studies on the Transmission of Hemolytic Streptococcus InfectionsI. Cross Infections in Army Hospital Wards , 1944 .

[65]  M. Hamburger.  Studies on the Transmission of Haemolytic Streptococcus Infections. II. Beta-Haemolytic Streptococci in the Saliva of Persons with Positive Throat Cultures. , 1944 .